Tourists can enjoy a joint there fairly easily, as abroad, but as for the locals, a new survey shows that Israelis are much less likely to have tried smoking grass than Europeans and Americans.

A number of popular bars and restaurants have opened in recent years in the area abutting the parking lot of Tel Aviv's Great Synagogue, of all places, and they have also become popular with young hip tourists from abroad.

LAS VEGAS — Clinicians should educate themselves and their patients if they choose to use medical marijuana in their practice, according to Michael E. Schatman, PhD, a clinical psychologist who has spent decades working in multidisciplinary chronic pain management. He presented on this topic during a session this week.

BETHESDA, Md., Sept. 8, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that Israeli patients with a medical cannabis license will now have access to Cannabics Pharmaceutical's cannabis oil Capsules.

Cannabics Pharmaceuticals executed an IP Licensing and Collaboration Agreement in Israel with Bazelet Pharma for the distribution of the Company's medical cannabis capsules in Israel through approved medical cannabis growers and in strict compliance with all laws and regulations in Israel.

From October 1, 2015, patients in Israel with a medical cannabis license shall be entitled to receive Cannabics oil capsules. These capsules are offered in two dosages: 1. Hermon-SR 10mg THC   2. Gilboa-SR 9.5mg THC, 0.5mg CBD.

Known for its dynamic tech startups, agricultural innovations, and security solutions, Israel could soon add cannabis powerhouse to the list, thanks to domestic efforts to decriminalize the drug… and a push to use it as a medical export.

Israel is already a leading global player in clinical testing and Israeli growers have been leveraging those clinical trials to produce new strains for decades. These growers have developed unique grow-how to deliver a medical grade product.

“O Lord my God, I cried unto Thee, and Thou didst heal me.” (Psalms 30:3)

Israeli researchers have long been on the cutting edge of medical marijuana research. Now a team of scientists from Tel Aviv University have shown that certain compounds found in cannabis can help treat multiple sclerosis-like diseases by preventing inflammation in the brain and spinal cord.

Israel is busy sorting out regulation for offshore natural gas reserves that are expected to be a boon for the local economy, while some argue that medical cannabis offers the Jewish state an even bigger financial opportunity.

Earlier this month, the Israel Loss Adjusters Association (ILAA) held a conference to discuss how Israel’s farmers could benefit from the growing global market for medical cannabis.

“The US cannabis market stands at $35 billion a year,” noted ILAA Chairman Doron Havkin. “Are we able to give up revenues from this market?”

The annual conference of the Israeli Association of Appraisers held in Tel Aviv last week focused on the ability of Israeli farmers to grow and export medical cannabis overseas, and the enormous profits such an endeavor would yield.

“The medical cannabis market in the US is valued at $35 billion a year, and those figures continue to grow with each passing day,” the association’s chairman Doron Havkin told the conference. “We must undertake a significant move in the field and start generating profits right away.”

Every species within the animal kingdom, contains the Endocannabinoid System (ECS), except for insects.

The ECS was named after cannabinoids, which are found abundantly in cannabis as well produced naturally within the human body.

Research conducted on cannabinoids such as THC, CBD, CBG and CBC that are produced by cannabis lead to the discovery of the Endocannabinoid System (ECS).

While Israel is busy sorting out regulation for the natural gas reserves off its shores, a development considered a boon for Israel’s economy, could it be missing an even bigger opportunity in the field of medical cannabis? That was the general consensus at a Thursday conference on how Israel’s farmers could benefit from the growing global market for medical cannabis, hosted by Israel Loss Adjusters Association.

“The US cannabis market stands at $35 billion a year.

Are we able to give up revenues from this market?” asked Doron Havkin, the ILAA’s chairman.

There is a great deal of excitement when you see how much it helps people,' says CEO of Tikun Olam, Israel’s largest grower of prescription cannabis. Yet the unusual business is not without its challenges.

Aharon Lutzky has a long career in Israeli industry, one that is characteristic of many CEOs who grew up on kibbutzim – until personal circumstances introduced him to medical cannabis.